Related Experiment Video
Updated: Aug 7, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Creating more effective antidepressants: clues from the clinic
1Lilly Research Laboratories, Eli Lilly & Co, Lilly Corporate Center, Indianapolis, IN 46285, USA. rasmussen_kurt@lilly.com
Drug Discovery Today
|June 24, 2006
Summary
Antidepressant medications help millions with depression and anxiety. New research suggests combining antidepressants with atypical antipsychotics may improve treatment for difficult-to-treat mood and anxiety disorders.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Antidepressant medications are widely used for depression and anxiety disorders.
- Limitations include delayed onset of action and suboptimal efficacy in some patients.
- Atypical antipsychotic agents are emerging as potential augmentation strategies.
Purpose of the Study:
- To explore the potential of atypical antipsychotic agents as augmentation therapy for antidepressant non-responders.
- To discuss the development of novel pharmacotherapies combining antidepressant and atypical antipsychotic properties.
Main Methods:
- Review of current literature on antidepressant and atypical antipsychotic efficacy.
- Analysis of emerging evidence for combination therapies.
- Discussion of potential mechanisms of action.
Main Results:
- Atypical antipsychotics show promise in augmenting antidepressant therapy for treatment-resistant depression and anxiety.
- Combined pharmacotherapy may offer faster and more effective symptom relief.
Conclusions:
- Combining antidepressant and atypical antipsychotic features in future drug development could significantly benefit patients with severe or refractory mood and anxiety disorders.
- This approach holds promise for conditions like obsessive-compulsive disorder, post-traumatic stress disorder, panic disorder, generalized anxiety disorder, and depression.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:54The Placebo Effect
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.